REATA PHARMACEUTICALS INC Operating Cash Flow
REATA PHARMACEUTICALS INC reported Operating Cash Flow of -$151.38 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-08-08
- REATA PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$69.93M.
- REATA PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$81.45M.
- REATA PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$50.43M.
- REATA PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$46.53M.
- REATA PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2022 was -$204.27M.
- REATA PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2021 was -$235.70M.
- REATA PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2020 was -$322.34M.
- REATA PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2019 was -$251.15M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$69.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$151.38M 10-Q · filed 2023-08-08 | -$201.80M derived: sum of 3 quarters · filed 2023-08-08 | -$248.34M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | -$81.45M 10-Q · filed 2023-05-10 | -$131.88M derived: sum of 2 quarters · filed 2023-05-10 | -$178.41M derived: sum of 3 quarters · filed 2023-05-10 | -$227.53M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | -$50.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$96.96M derived: sum of 2 quarters · filed 2023-02-24 | -$146.08M derived: sum of 3 quarters · filed 2023-08-08 | -$204.27M 10-K · filed 2023-02-24 |
| 2022-09-30 | -$46.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$95.66M derived: sum of 2 quarters · filed 2023-08-08 | -$153.84M 10-Q · filed 2022-11-08 | -$276.77M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | -$49.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$107.31M 10-Q · filed 2023-08-08 | -$230.24M derived: sum of 3 quarters · filed 2023-08-08 | -$272.40M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$58.19M 10-Q · filed 2023-05-10 | -$181.12M derived: sum of 2 quarters · filed 2023-05-10 | -$223.28M derived: sum of 3 quarters · filed 2023-05-10 | -$248.88M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$122.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$165.09M derived: sum of 2 quarters · filed 2023-02-24 | -$190.69M derived: sum of 3 quarters · filed 2023-02-24 | -$235.70M 10-K · filed 2023-02-24 |
| 2021-09-30 | -$42.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$67.76M derived: sum of 2 quarters · filed 2022-11-08 | -$112.77M 10-Q · filed 2022-11-08 | -$157.91M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | -$25.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$70.61M 10-Q · filed 2022-08-08 | -$115.75M derived: sum of 3 quarters · filed 2023-02-24 | -$155.84M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | -$45.01M 10-Q · filed 2022-05-10 | -$90.15M derived: sum of 2 quarters · filed 2023-02-24 | -$130.24M derived: sum of 3 quarters · filed 2023-02-24 | -$326.18M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | -$45.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$85.23M derived: sum of 2 quarters · filed 2023-02-24 | -$281.17M derived: sum of 3 quarters · filed 2023-02-24 | -$322.34M 10-K · filed 2023-02-24 |
| 2020-09-30 | -$40.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$236.03M derived: sum of 2 quarters · filed 2021-11-08 | -$277.20M 10-Q · filed 2021-11-08 | -$426.57M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$195.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$237.11M 10-Q · filed 2021-08-09 | -$386.48M derived: sum of 3 quarters · filed 2022-02-28 | -$426.82M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$41.17M 10-Q · filed 2021-05-06 | -$190.55M derived: sum of 2 quarters · filed 2022-02-28 | -$230.88M derived: sum of 3 quarters · filed 2022-02-28 | -$263.59M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$149.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$189.71M derived: sum of 2 quarters · filed 2022-02-28 | -$222.42M derived: sum of 3 quarters · filed 2022-02-28 | -$251.15M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$40.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$73.04M derived: sum of 2 quarters · filed 2020-11-09 | -$101.78M 10-Q · filed 2020-11-09 | -$139.27M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$32.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$61.44M 10-Q · filed 2020-08-10 | -$98.94M derived: sum of 3 quarters · filed 2021-03-01 | -$95.80M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$28.73M 10-Q · filed 2020-05-11 | -$66.23M derived: sum of 2 quarters · filed 2021-03-01 | -$63.09M derived: sum of 3 quarters · filed 2021-03-01 | -$88.49M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$37.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$34.35M derived: sum of 2 quarters · filed 2021-03-01 | -$59.76M derived: sum of 3 quarters · filed 2021-03-01 | -$83.78M 10-K · filed 2021-03-01 |
| 2018-09-30 | $3.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$22.27M derived: sum of 2 quarters · filed 2019-11-12 | -$46.29M 10-Q · filed 2019-11-12 | -$71.02M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | -$25.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$49.43M 10-Q · filed 2019-08-08 | -$74.16M derived: sum of 3 quarters · filed 2020-02-19 | -$93.19M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | -$24.02M 10-Q · filed 2019-05-09 | -$48.75M derived: sum of 2 quarters · filed 2020-02-19 | -$67.78M derived: sum of 3 quarters · filed 2020-02-19 | |
| 2017-12-31 | -$24.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$43.76M derived: sum of 2 quarters · filed 2020-02-19 | -$83.26M 10-K · filed 2020-02-19 | |
| 2017-09-30 | -$19.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$58.52M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$39.49M 10-Q · filed 2018-08-08 | |||
| 2016-12-31 | -$19.26M 10-K · filed 2019-02-28 |